Home : Site Map | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Pulmonary Function TestingCase 5 AnswerA 41 year-old woman presents to the General Internal Medicine Clinic at Harborview Medical Center complaining of dyspnea with mild exertion. She has a 10 pack-year history of smoking and a history of using intravenous drugs including heroin and ritalin. Her pulmonary function testing is as follows:
His flow volume loops is as follows: Case 5 InterpretationThis patient has evidence of air-flow obstruction, as her FEV1, FVC and her FEV1/FVC are all decreased. Her flow volume demonstrates the characteristic scooped-out appearance seen in obstructive lung disease and also demonstrates markedly reduced peak expiratory flows. Based on her FEV1 of 19% predicted this would be classified as “very severe” obstructive lung disease. The patient also has evidence of air-trapping, as her RV is 257% predicted. She would not be classified as being hyper-inflated because her TLC is only 108% predicted. There is no evidence of a bronchodilator response as her FVC and FEV1 both decline following bronchodilator administration. Her DLCO is also decreased, indicating a loss of alveolar-capillary surface area for gas exchange. It is highly unlikely for a 41 year-old person to have obstructive lung disease with only a 10-pack year history of smoking. Asthma is an unlikely diagnosis given the absence of reversibility with bronchodilator administration. Her chest x-ray provides some clues to the diagnosis, however. There is marked hyper-lucency at the bases, suggesting that this is a basilar-predominant form of emphysema. The minor fissure (arrow) is also shifted upward on the right side, indicating that the lower lobes are over-inflated. Two disorders can give you early-onset emphysema with a basilar predominance: alpha-one anti-trypsin deficiency (it is usually only seen this early if the person also smokes) and ritalin lung. The latter is an uncommon form of the severe basilar-predominant emphysema seen in people who previously used intravenous injections of ritalin (methylphenidate). |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Home : Search : Site
Map UW School of Medicine : School of Medicine Mission |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2008 University
of Washington. All rights reserved. Copyright and Disclaimer : Credits and Acknowledgements |